DDD Announces the Start of its Extended Release CDT-Pseudoephedrine Human Trials
Tweet Send to a Friend
SCOLR Pharma, Inc. (Amex: DDD) announced today that it has initiated ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
